Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 9/23/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Thomas F. Schaible PhD

Wrong Dr. Thomas F. Schaible PhD?

Vice President, Medical Affairs

Janssen Products , LP.
Local Address: Horsham, Pennsylvania, United States
Janssen L.P
1125 Trenton Harbourton Road
Titusville , New Jersey 08560
United States

Company Description: Janssen Pharmaceutica Products, L.P., is a member of the Johnson & Johnson family of companies, the world's most comprehensive and broadly based manufacturer of...   more
Background

Employment History

Education

  • PhD , physiology
    Rutgers University
  • BS , biology
    Trinity College
  • Ph.D.
78 Total References
Web References
As CKD severity progresses in patients ...
www.paragonrx.com, 27 June 2011 [cached]
As CKD severity progresses in patients not on dialysis, anemia becomes more frequent and severe, and is almost universal among patients requiring dialysis," said Thomas Schaible, Ph.D., Vice President, Medical Affairs, Janssen Products, LP.
Pharmanews.net
www.pharmanews.net, 18 June 2002 [cached]
"Rheumatoid arthritis can be an extremely debilitating disease," said Thomas Schaible, Ph.D., executive director, medical affairs, Centocor.
"Anemia is a frequent complication of ...
www.prnewswire.com, 24 June 2011 [cached]
"Anemia is a frequent complication of CKD in patients not yet on dialysis as well as in patients on dialysis, and untreated may lead to the requirement for blood transfusions.  As CKD severity progresses in patients not on dialysis, anemia becomes more frequent and severe, and is almost universal among patients requiring dialysis," said Thomas Schaible, Ph.D., Vice President, Medical Affairs, Janssen Products, LP.  "PROCRIT is an important treatment option for patients with CKD-associated anemia who are not on dialysis and are likely to require transfusion.  The revised label provides additional clarification to prescribers on how to use PROCRIT in this patient segment."
Thomas Schaible, vice ...
www.paragonrx.com, 27 June 2011 [cached]
Thomas Schaible, vice president of medical affairs at Janssen added that "Procrit is an important treatment option for patients with CKD-associated anaemia who are not on dialysis and are likely to require transfusion," adding that "the revised label provides additional clarification to prescribers on how to use Procrit in this patient segment."
"Having been a part of its ...
www.biotechnologyhealthcare.com, 6 Nov 2007 [cached]
"Having been a part of its initial approval in 1998, I have personally witnessed how REMICADE has satisfied unmet therapeutic needs and resulted in significant life-changing improvements in patients," said Thomas F. Schaible, PhD, Vice President, Medical Affairs, Centocor, Inc.
Other People with the name "Schaible":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304